Sanofi SNYNF

SNYNF Company Overview

Sanofi is a global biopharmaceutical company headquartered in Paris, France, focused on the research, development, manufacturing, and commercialization of prescription medicines and vaccines. The company operates across the pharmaceutical and healthcare industries, with a primary emphasis on specialty care, immunology, rare diseases, oncology, vaccines, and general medicines. According to SEC filings, annual reports, and major financial publications, Sanofi’s core revenue drivers include its immunology franchise led by Dupixent, vaccines produced through Sanofi Pasteur, and specialty therapeutics targeting chronic and rare conditions.

Sanofi serves healthcare providers, hospitals, governments, pharmacies, and patients across developed and emerging markets. The company has evolved from a diversified pharmaceutical conglomerate into a more focused biopharmaceutical organization emphasizing innovative medicines and biologics. Sanofi’s strategic positioning is supported by its extensive global commercial infrastructure, large-scale vaccine manufacturing capabilities, and longstanding partnerships in biotechnology and life sciences. The company traces its roots to the formation of Sanofi in 1973 and expanded significantly through mergers and acquisitions, including the acquisition of Aventis in 2004 and Genzyme in 2011, which strengthened its presence in specialty care and rare diseases.